Metabolic Syndrome and Inflammation

作者: Rodica Pop-Busui , Massimo Pietropaolo

DOI: 10.1007/978-1-60327-478-4_5

关键词:

摘要: The “metabolic syndrome” is a cluster of cardiovascular disease (CVD) risk factors including abdominal obesity, hyperlipidemia, hypertension, insulin resistance, and hyperglycemia. These components reflecting overnutrition, sedentary lifestyles, resultant excess adiposity may associate with various conditions therefore multiple definitions were developed over time. prevalence metabolic syndrome increasing at rates paralleling the epidemic type 2 diabetes in USA as well rest world developing nations. Unlike autoimmune diabetes, accumulating evidence suggests that strongly linked to chronic systemic inflammation. presence associated an approximate doubling fivefold increased for incident diabetes. Although it unclear whether unifying pathophysiological mechanism results specific clinical clusters syndrome, subsequent inflammation oxidative stress resistance appear play central role. Landmark investigations inflammasome activity provide great potential insights into molecular basis inflammatory nature beginning story continues unfold. evolving concept hypertension having common provides new opportunities strategies, currently underway, correct consequences

参考文章(162)
Dimitris A Papanicolaou, Ronald L Wilder, Stavros C Manolagas, George P Chrousos, The Pathophysiologic Roles of Interleukin-6 in Human Disease Annals of Internal Medicine. ,vol. 128, pp. 127- 137 ,(1998) , 10.7326/0003-4819-128-2-199801150-00009
E.Allison Green, Richard A Flavell, The Temporal Importance of TNFα Expression in the Development of Diabetes Immunity. ,vol. 12, pp. 459- 469 ,(2000) , 10.1016/S1074-7613(00)80198-3
Duanping Liao, Jianwen Cai, Frederick L. Brancati, Aaron Folsom, Ralph W. Barnes, Herman A. Tyroler, Gerardo Heiss, Association of vagal tone with serum insulin, glucose, and diabetes mellitus — The ARIC Study☆ Diabetes Research and Clinical Practice. ,vol. 30, pp. 211- 221 ,(1995) , 10.1016/0168-8227(95)01190-0
L.H. Kuller, L. Shemanski, B.M. Psaty, N.O. Borhani, J. Gardin, M.N. Haan, D.H. O’Leary, P.J. Savage, G.S. Tell, R. Tracy, Subclinical Disease as an Independent Risk Factor for Cardiovascular Disease Circulation. ,vol. 92, pp. 720- 726 ,(1995) , 10.1161/01.CIR.92.4.720
G. Winkler, O. Dworak, F. Salamon, D. Salamon, G. Speer, K. Cseh, Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetologia. ,vol. 41, pp. 488- 488 ,(1998) , 10.1007/S001250050935
D. T. Fearon, R. M. Locksley, The instructive role of innate immunity in the acquired immune response. Science. ,vol. 272, pp. 50- 54 ,(1996) , 10.1126/SCIENCE.272.5258.50
Gabriele Weitz-Schmidt, Statins as anti-inflammatory agents Trends in Pharmacological Sciences. ,vol. 23, pp. 482- 487 ,(2002) , 10.1016/S0165-6147(02)02077-1
, N. Unwin, J. Shaw, P. Zimmet, K. G. M. M. Alberti, Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention Diabetic Medicine. ,vol. 19, pp. 708- 723 ,(2002) , 10.1046/J.1464-5491.2002.00835.X
Uwe Schönbeck, Nerea Varo, Peter Libby, Julie Buring, Paul M Ridker, None, Soluble CD40L and Cardiovascular Risk in Women Circulation. ,vol. 104, pp. 2266- 2268 ,(2001) , 10.1161/HC4401.099447
Shizuo Akira, Satoshi Uematsu, Osamu Takeuchi, Pathogen Recognition and Innate Immunity Cell. ,vol. 124, pp. 783- 801 ,(2006) , 10.1016/J.CELL.2006.02.015